Our goal:
Reduce cardiovascular disease, diabetes type 2 and their complications in our community.*
-
Cardiovascular disease can be broken down into coronary artery disease (heart), cerebrovascular disease (brain) and peripheral vascular disease (veins and arteries).
These include heart attacks, strokes, heart failure, ischaemic cardiomyopathies and critical limb ischaemia.
-
1. Screening for cardiovascular risk factors and metabolic syndrome through medical aid wellness and screening programmes, yearly medicals and general consultations.
2. Identify patients with high 10 year risk and/or life time risk for cardiovascular disease.
3. Implement Primary Prevention Strategies.
4. Implement Secondary Prevention Strategies.
5. Health advocacy measures through social media.
6. Monitor patients enrolled on primary prevention and secondary prevention programmes.
7. Report on patients enrolled in these programmes.
-
During general consultations, yearly medicals or wellness consultations.
We screen patients by measuring their weight, height, BMI, waist circumference, blood glucose levels, lipid levels, blood pressure, social habits, exercise routines and eating habits.
We use the Framingham Risk Score as well as the ASCVD Risk Estimator Plus for assessing our patients 10 year risk or lifetime risk for cardiovascular disease.
*Refer to our strategic goals 2022 for our measurable outcomes.
What is metabolic syndrome?
According to the IDF and NCEP ATP-III metabolic syndrome is a combination of any three of the five features.
1) Increased waist circumference
2) Raised triglycerides
3) Low HDL (good) cholesterol
4) High blood pressure
5) Abnormal fasting blood glucose
-
People with metabolic syndrome have increased risk of cardiovascular disease (heart attacks and strokes) and type 2 diabetes.
-
Primary prevention is focused on firstly, identifying patients with metabolic syndrome, cardiovascular risk factors and/or high risk for cardiovascular disease.
Secondly, managing these patients by initiating clinician-patient discussions and then introducing risk lowering interventions, through lifestyle changes and medication.
The aim is to reduce the incidence (new cases) of cardiovascular disease and diabetes type 2.
-
Secondary prevention is focused on managing patients identified with cardiovascular disease and or diabetes type 2 in order to reduce further morbidity (“suffering” or “new events”) and mortality (“death”).